Thorne HealthTech, Inc.

NasdaqGS:THRN Stock Report

Market Cap: US$550.6m

Thorne HealthTech Valuation

Is THRN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of THRN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: THRN ($10.19) is trading below our estimate of fair value ($23.52)

Significantly Below Fair Value: THRN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for THRN?

Key metric: As THRN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for THRN. This is calculated by dividing THRN's market cap by their current earnings.
What is THRN's PE Ratio?
PE Ratio27.1x
EarningsUS$20.33m
Market CapUS$550.63m

Price to Earnings Ratio vs Peers

How does THRN's PE Ratio compare to its peers?

The above table shows the PE ratio for THRN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average19.3x
HKHC Horizon Kinetics Holding
37xn/aUS$722.1m
USNA USANA Health Sciences
13.8x-0.7%US$768.9m
HLF Herbalife
9.2x50.6%US$799.3m
NATR Nature's Sunshine Products
17.3x6.4%US$295.6m
THRN Thorne HealthTech
27.1x57.2%US$550.6m

Price-To-Earnings vs Peers: THRN is expensive based on its Price-To-Earnings Ratio (27.1x) compared to the peer average (22.9x).

Price to Earnings Ratio vs Industry

How does THRN's PE Ratio compare vs other companies in the US Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NEPT.F Neptune Wellness Solutions
n/an/aUS$4.00
No more companies available in this PE range
THRN 27.1xIndustry Avg. 26.6xNo. of Companies4PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: THRN is expensive based on its Price-To-Earnings Ratio (27.1x) compared to the US Personal Products industry average (26.8x).

Price to Earnings Ratio vs Fair Ratio

What is THRN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

THRN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio27.1x
Fair PE Ratio37.2x

Price-To-Earnings vs Fair Ratio: THRN is good value based on its Price-To-Earnings Ratio (27.1x) compared to the estimated Fair Price-To-Earnings Ratio (37.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst THRN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Nov ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Oct ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Sep ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Aug ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Jul ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Jun ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
May ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Apr ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Mar ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Feb ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Jan ’25n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Dec ’24n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Nov ’24n/a
US$8.60
0%
11.6%US$10.00US$7.80n/a3
Oct ’24US$10.19
US$8.80
-13.6%
12.1%US$10.20US$7.80n/a5
Sep ’24US$10.17
US$8.80
-13.5%
12.1%US$10.20US$7.80n/a5
Aug ’24US$5.67
US$7.50
+32.3%
11.5%US$8.00US$6.00n/a4
Jul ’24US$4.70
US$7.00
+48.9%
14.3%US$8.00US$6.00n/a4
Jun ’24US$4.74
US$6.80
+43.5%
14.4%US$8.00US$6.00n/a5
May ’24US$4.35
US$6.80
+56.3%
14.4%US$8.00US$6.00n/a5
Apr ’24US$4.62
US$6.90
+49.4%
14.8%US$8.00US$5.50n/a5
Mar ’24US$4.71
US$6.90
+46.5%
14.8%US$8.00US$5.50n/a5
Feb ’24US$4.67
US$6.90
+47.8%
14.8%US$8.00US$5.50n/a5
Jan ’24US$3.63
US$6.90
+90.1%
14.8%US$8.00US$5.50n/a5
Dec ’23US$4.89
US$6.90
+41.1%
14.8%US$8.00US$5.50n/a5
Nov ’23US$4.87
US$8.00
+64.3%
8.8%US$9.00US$7.00n/a4

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

Reynolds Consumer Products

US$5.7b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.47

7D

-0.3%

1Y

3.8%

USANA Health Sciences

US$768.9m

Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

USNA

US$39.38

7D

-4.6%

1Y

-14.8%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.8b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.Y

Mex$7.05

7D

-0.3%

1Y

-30.2%